-
Je něco špatně v tomto záznamu ?
Molecular Profiling of Sinonasal Adenoid Cystic Carcinoma: Canonical and Noncanonical Gene Fusions and Mutation
A. Skálová, M. Bradová, A. Agaimy, J. Laco, C. Badual, S. Ihrler, I. Damjanov, NJ. Rupp, CE. Bacchi, S. Mueller, S. Ventelä, D. Zhang, E. Comperat, P. Martínek, R. Šíma, T. Vaněček, P. Grossmann, P. Steiner, V. Hájková, I. Kovářová, M. Michal, I. Leivo
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- adenoidně cystický karcinom * genetika patologie MeSH
- dospělí MeSH
- fenotyp MeSH
- fúze genů MeSH
- fúzní onkogenní proteiny genetika MeSH
- genetická predispozice k nemoci MeSH
- hybridizace in situ fluorescenční * MeSH
- imunohistochemie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mutace * MeSH
- mutační analýza DNA MeSH
- nádorové biomarkery * genetika MeSH
- nádory vedlejších dutin nosních * genetika patologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- transkripční faktory NFI genetika MeSH
- vysoce účinné nukleotidové sekvenování * MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Adenoid cystic carcinomas (AdCC) of salivary gland origin have long been categorized as fusion-defined carcinomas owing to the almost universal presence of the gene fusion MYB::NFIB , or less commonly MYBL1::NFIB. Sinonasal AdCC is an aggressive salivary gland malignancy with no effective systemic therapy. Therefore, it is urgent to search for potentially targetable genetic alterations associated with AdCC. We have searched the authors' registries and selected all AdCCs arising in the sinonasal tract. The tumors were examined histologically, immunohistochemically, by next generation sequencing (NGS) and/or fluorescence in situ hybridization (FISH) looking for MYB/MYBL1 and/or NFIB gene fusions or any novel gene fusions and/or mutations. In addition, all tumors were tested for HPV by genotyping using (q)PCR. Our cohort comprised 88 cases of sinonasal AdCC, predominantly characterized by canonical MYB::NFIB (49 cases) and MYBL1::NFIB (9 cases) fusions. In addition, noncanonical fusions EWSR1::MYB ; ACTB::MYB; ESRRG::DNM3 , and ACTN4::MYB were identified by NGS, each of them in 1 case. Among nine fusion-negative AdCCs, FISH detected rearrangements in MYB (7 cases) , NFIB (1 case), and EWSR1 (1 case). Six AdCCs lacked fusions or gene rearrangements, while 11 cases were unanalyzable. Mutational analysis was performed by NGS in 31/88 (35%) AdCCs. Mutations in genes with established roles in oncogenesis were identified in 21/31 tumors (68%), including BCOR (4/21; 19%), NOTCH1 (3/21; 14%), EP300 (3/21; 14%), SMARCA4 (2/21; 9%), RUNX1 (2/21; 9%), KDM6A (2/21; 9%), SPEN (2/21; 9%), and RIT1, MGA, RB1, PHF6, PTEN, CREBBP, DDX41, CHD2, ROS1, TAF1, CCD1, NF1, PALB2, AVCR1B, ARID1A, PPM1D, LZTR1, GEN1 , PDGFRA , each in 1 case (1/21; 5%). Additional 24 cases exhibited a spectrum of gene mutations of uncertain pathogenetic significance. No morphologic differences were observed between AdCCs with MYBL1::NFIB and MYB::NFIB fusions. Interestingly, mutations in the NOTCH genes were seen in connection with both canonical and noncanonical fusions, and often associated with high-grade histology or metatypical phenotype, as well as with poorer clinical outcome. Noncanonical fusions were predominantly observed in metatypical AdCCs. These findings emphasize the value of comprehensive molecular profiling in correlating morphologic characteristics, genetic landscape, and clinical behavior in AdCC.
Consultoria em Patologia Botucatu São Paulo Brazil
Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Erlangen Erlanden
Department of Pathology and Molecular Pathology University Hospital Zurich Zurich Switzerland
Department of Pathology Charles University Faculty of Medicine in Pilsen
Department of Pathology Medical University of Vienna Vienna Austria
Department of Pathology Tenon Hospital Sorbonne University Paris France
Departments of Otorhinolaryngology
Institute of Biomedicine Pathology University of Turku Turku Finland
Institute of Pathology University Hospital Erlangen Friedrich Alexander University Erlangen Nürnberg
Molecular and Genetic Laboratory Bioptic Laboratory Ltd Pilsen
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009706
- 003
- CZ-PrNML
- 005
- 20250429134501.0
- 007
- ta
- 008
- 250415s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PAS.0000000000002349 $2 doi
- 035 __
- $a (PubMed)39760648
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Skálová, Alena $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen $u Bioptic Laboratory Ltd
- 245 10
- $a Molecular Profiling of Sinonasal Adenoid Cystic Carcinoma: Canonical and Noncanonical Gene Fusions and Mutation / $c A. Skálová, M. Bradová, A. Agaimy, J. Laco, C. Badual, S. Ihrler, I. Damjanov, NJ. Rupp, CE. Bacchi, S. Mueller, S. Ventelä, D. Zhang, E. Comperat, P. Martínek, R. Šíma, T. Vaněček, P. Grossmann, P. Steiner, V. Hájková, I. Kovářová, M. Michal, I. Leivo
- 520 9_
- $a Adenoid cystic carcinomas (AdCC) of salivary gland origin have long been categorized as fusion-defined carcinomas owing to the almost universal presence of the gene fusion MYB::NFIB , or less commonly MYBL1::NFIB. Sinonasal AdCC is an aggressive salivary gland malignancy with no effective systemic therapy. Therefore, it is urgent to search for potentially targetable genetic alterations associated with AdCC. We have searched the authors' registries and selected all AdCCs arising in the sinonasal tract. The tumors were examined histologically, immunohistochemically, by next generation sequencing (NGS) and/or fluorescence in situ hybridization (FISH) looking for MYB/MYBL1 and/or NFIB gene fusions or any novel gene fusions and/or mutations. In addition, all tumors were tested for HPV by genotyping using (q)PCR. Our cohort comprised 88 cases of sinonasal AdCC, predominantly characterized by canonical MYB::NFIB (49 cases) and MYBL1::NFIB (9 cases) fusions. In addition, noncanonical fusions EWSR1::MYB ; ACTB::MYB; ESRRG::DNM3 , and ACTN4::MYB were identified by NGS, each of them in 1 case. Among nine fusion-negative AdCCs, FISH detected rearrangements in MYB (7 cases) , NFIB (1 case), and EWSR1 (1 case). Six AdCCs lacked fusions or gene rearrangements, while 11 cases were unanalyzable. Mutational analysis was performed by NGS in 31/88 (35%) AdCCs. Mutations in genes with established roles in oncogenesis were identified in 21/31 tumors (68%), including BCOR (4/21; 19%), NOTCH1 (3/21; 14%), EP300 (3/21; 14%), SMARCA4 (2/21; 9%), RUNX1 (2/21; 9%), KDM6A (2/21; 9%), SPEN (2/21; 9%), and RIT1, MGA, RB1, PHF6, PTEN, CREBBP, DDX41, CHD2, ROS1, TAF1, CCD1, NF1, PALB2, AVCR1B, ARID1A, PPM1D, LZTR1, GEN1 , PDGFRA , each in 1 case (1/21; 5%). Additional 24 cases exhibited a spectrum of gene mutations of uncertain pathogenetic significance. No morphologic differences were observed between AdCCs with MYBL1::NFIB and MYB::NFIB fusions. Interestingly, mutations in the NOTCH genes were seen in connection with both canonical and noncanonical fusions, and often associated with high-grade histology or metatypical phenotype, as well as with poorer clinical outcome. Noncanonical fusions were predominantly observed in metatypical AdCCs. These findings emphasize the value of comprehensive molecular profiling in correlating morphologic characteristics, genetic landscape, and clinical behavior in AdCC.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a adenoidně cystický karcinom $x genetika $x patologie $7 D003528
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a nádory vedlejších dutin nosních $x genetika $x patologie $7 D010255
- 650 12
- $a nádorové biomarkery $x genetika $7 D014408
- 650 12
- $a hybridizace in situ fluorescenční $7 D017404
- 650 12
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a fúzní onkogenní proteiny $x genetika $7 D015514
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a fúze genů $7 D050939
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a transkripční faktory NFI $x genetika $7 D051839
- 650 _2
- $a mladiství $7 D000293
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bradová, Martina $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen $u Bioptic Laboratory Ltd
- 700 1_
- $a Agaimy, Abbas $u Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU)
- 700 1_
- $a Laco, Jan $u The Fingerland Department of Pathology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Badual, Cécile $u Service d'Anatomo-Pathologie, Department of Pathology, Hôpital Européen G Pompidou, APHP, Université de Paris
- 700 1_
- $a Ihrler, Stephan $u Dermpath, Muenchen, Germany
- 700 1_
- $a Damjanov, Ivan $u The University of Kansas School of Medicine
- 700 1_
- $a Rupp, Niels J $u Department of Pathology, and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland
- 700 1_
- $a Bacchi, Carlos E $u Consultoria em Patologia, Botucatu, São Paulo, Brazil
- 700 1_
- $a Mueller, Sarina $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Erlangen, Erlanden
- 700 1_
- $a Ventelä, Sami $u Departments of Otorhinolaryngology
- 700 1_
- $a Zhang, Da $u Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS
- 700 1_
- $a Comperat, Eva $u Department of Pathology, Tenon Hospital, Sorbonne University, Paris, France $u Department of Pathology, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Martínek, Petr $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
- 700 1_
- $a Šíma, Radek $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
- 700 1_
- $a Vaněček, Tomas $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
- 700 1_
- $a Grossmann, Petr $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
- 700 1_
- $a Steiner, Petr $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
- 700 1_
- $a Hájková, Veronka $u Molecular and Genetic Laboratory, Bioptic Laboratory Ltd, Pilsen
- 700 1_
- $a Kovářová, Inka $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen
- 700 1_
- $a Michal, Michal $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen $u Bioptic Laboratory Ltd
- 700 1_
- $a Leivo, Ilmo $u Pathology, Turku University Hospital $u Institute of Biomedicine, Pathology, University of Turku, Turku, Finland
- 773 0_
- $w MED00000304 $t The American journal of surgical pathology $x 1532-0979 $g Roč. 49, č. 3 (2025), s. 227-242
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39760648 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429134456 $b ABA008
- 999 __
- $a ok $b bmc $g 2311215 $s 1246787
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 49 $c 3 $d 227-242 $e 20250106 $i 1532-0979 $m The American journal of surgical pathology $n Am J Surg Pathol $x MED00000304
- LZP __
- $a Pubmed-20250415